Author

Z. Georgieva

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell-cell communication· 1 Assay:flow cytometry· 1

Frequent Co-Authors

D. Rainbow· 2 shared J. L. Jones· 2 shared A. Coles· 1 shared A. Prabhu· 1 shared C. M. Gaunt· 1 shared E. Needham· 1 shared H. Mousa· 1 shared H. S. Mousa· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

D. Rainbow

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintDec 24, 2023

Hiding in Plain Sight: Thymic CD8+FOXP3+Tregs sequester CD25 and are enriched in human tissues

L. B. Jarvis, S. K. Howlett, D. Rainbow…·J. L. Jones

The paper identifies CD8+FOXP3+ Tregs enriched in human tissues, expressing intracellular CD25 and tissue residency markers, and demonstrates their therapeutic potential and association with disease states.

DOI 10.1101/2023.12.24.573232

humanflow cytometry

𝕏 PostBluesky

ImmunologybioRxivFeb 17, 2021

The MS remyelinating drug bexarotene (an RXR agonist) promotes induction of human Tregs and suppresses Th17 differentiation in vitro

C. M. Gaunt, D. Rainbow, R. MacKenzie…·J. L. Jones

This study shows bexarotene, an RXR agonist, promotes Treg induction and suppresses Th17 differentiation in human CD4 T cells, independent of tRA and RAR signaling.

DOI 10.3389/fimmu.2021.712241

humanproteomics

𝕏 PostBluesky